Cite
Carcinogenicity and hormone studies with the tissue-selective estrogen receptor modulator bazadoxifene
MLA
Barry S. Komm, et al. “Carcinogenicity and Hormone Studies with the Tissue-Selective Estrogen Receptor Modulator Bazadoxifene.” Journal of Cellular Physiology, vol. 228, Dec. 2012, pp. 724–33. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1931ebeec185c1f9291cf07ff908a4b1&authtype=sso&custid=ns315887.
APA
Barry S. Komm, David J. Wright, Mark A. Cukierski, Richard Perry, Daniel R. Minck, Steven Bailey, & J. Nicole Earnhardt. (2012). Carcinogenicity and hormone studies with the tissue-selective estrogen receptor modulator bazadoxifene. Journal of Cellular Physiology, 228, 724–733.
Chicago
Barry S. Komm, David J. Wright, Mark A. Cukierski, Richard Perry, Daniel R. Minck, Steven Bailey, and J. Nicole Earnhardt. 2012. “Carcinogenicity and Hormone Studies with the Tissue-Selective Estrogen Receptor Modulator Bazadoxifene.” Journal of Cellular Physiology 228 (December): 724–33. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1931ebeec185c1f9291cf07ff908a4b1&authtype=sso&custid=ns315887.